The different paths taken by European and American regulators on diabetes drug Avandia raise questions about where the Food and Drug Administration is headed.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/09/23/130078947/does-avandia-decision-signal-new-fda-or-same-old?ft=1&f=103537970
Posted
Sep 23 2010, 01:05 PM
by
NPR Blogs: Shots - Health News Blog